Maria Marcu

Dr. Maria Marcu


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in European Journal of Radiology
Verified
Journal Article
Closed access
MHMihaela Hedesiu
Mihaela Hedesiu
MMMaria Marcu
Maria Marcu
BSBenjamin Salmon
Benjamin Salmon
RPRuben Pauwels
Ruben Pauwels
AOAnne Caroline Oenning
Anne Caroline Oenning
RJReinhilde Jacobs
Reinhilde Jacobs

1 January 2022 in Chirurgia
Verified
Journal Article
Closed access
Dana IancuDana Iancu
Dana Iancu
MBMaria Budusan
Maria Budusan
DCDenisa Capras
Denisa Capras
AOAndrei Odaini
Andrei Odaini
HBHorea Bocse
Horea Bocse
CBClaudiu Iulian Badulescu
Claudiu Iulian Badulescu
Pancreatic adenocarcinoma is a very aggressive tumor with a low overall survival rate. The prognostic and the treatment of this disease are strongly interconnected and highly dependent on the resectability criteria of the tumor, surgical excision being the golden standard. For local advance disease or for unresectable tumors, with or without metastasis we can take into consideration as adjuvant therapy, together with chemotherapy, the radiofrequency ablation or stereotactic ablation radiotherapy of the solid tumor mass. This article is a narrative review that aims to describe these two interventional techniques: radiofrequency ablation and stereotactic ablation radiotherapy. We will discuss the techniques themselves, benefits that they bring and also, about the possible complications that can appear when using them in the management of pancreatic cancer.